CRISPR Therapeutics AG (CRSP) Shares Outstanding (Diluted) (2016 - 2026)
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Shares Outstanding (Diluted) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.42 Bn | 112.79 Mn | 30.66 Mn |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | 96.51 Mn |
| 3 | Iovance Biotherapeutics | 3.78 Bn | 3.49 Bn | 55.72 Mn | 450.19 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 184.32 Mn |
| 5 | uniQure | 3.06 Bn | 3.06 Bn | 5.49 Mn | 66.24 Mn |
| 6 | Beam Therapeutics | 2.68 Bn | 2.68 Bn | - | 104.33 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 413.69 Mn |
| 8 | Sarepta Therapeutics | 2.35 Bn | 1.55 Bn | 251.87 Mn | 105.43 Mn |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn | 52.31 Mn |
| 10 | Taysha Gene Therapies | 1.99 Bn | 1.99 Bn | - | 369.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 96.51 Mn |
| Mar 31, 2026 | 96.05 Mn |
| Dec 31, 2025 | 89.93 Mn |
| Sep 30, 2025 | 91.31 Mn |
| Jun 30, 2025 | 87.07 Mn |
| Mar 31, 2025 | 85.94 Mn |
| Dec 31, 2024 | 84.36 Mn |
| Sep 30, 2024 | 85.23 Mn |
| Jun 30, 2024 | 84.92 Mn |
| Mar 31, 2024 | 81.79 Mn |
| Dec 31, 2023 | 79.22 Mn |
| Sep 30, 2023 | 79.41 Mn |
| Jun 30, 2023 | 79.09 Mn |
| Mar 31, 2023 | 78.68 Mn |
| Dec 31, 2022 | 77.75 Mn |
| Sep 30, 2022 | 78.02 Mn |
| Jun 30, 2022 | 77.51 Mn |
| Mar 31, 2022 | 77.10 Mn |
| Dec 31, 2021 | 80.39 Mn |
| Sep 30, 2021 | 76.29 Mn |